Evidence map›Paper›PMID 34652509›Full record

ArticleEuropean journal of pediatrics2022

Neurological and neurodevelopmental symptoms in children with familial Mediterranean fever and their siblings.

Oren Biro, Alex Gileles-Hillel, Talia Dor-Wollman, Eli M Eisenstein, Yackov Berkun

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Prevalence of neurological manifestation in familial mediterranean fever patients: systematic review & meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Neurological Face of Familial Mediterranean Fever.Turkish archives of pediatrics · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Oren Biro *Department of Pediatrics, Hadassah-Hebrew University Medical Center, POB 24035, 91240, Mount ScopusJerusalem, Israel.
Alex Gileles-Hillel *Department of Pediatrics, Hadassah-Hebrew University Medical Center, POB 24035, 91240, Mount ScopusJerusalem, Israel.
Talia Dor-WollmanDepartment of Pediatrics, Hadassah-Hebrew University Medical Center, POB 24035, 91240, Mount ScopusJerusalem, Israel.
Eli M EisensteinDepartment of Pediatrics, Hadassah-Hebrew University Medical Center, POB 24035, 91240, Mount ScopusJerusalem, Israel.
Yackov BerkunDepartment of Pediatrics, Hadassah-Hebrew University Medical Center, POB 24035, 91240, Mount ScopusJerusalem, Israel. berkun@hadassah.org.il.ORCID http://orcid.org/0000-0001-9823-4750
Hebrew University of Jerusalem · ILHadassah Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Familial Mediterranean fever is a common autoinflammatory disease characterized by periodic attacks of fever and serositis. There are few reports describing neurological symptoms in patients with FMF. The aim of this study was to systematically assess the neurologic and developmental involvement in pediatric patients with FMF. Between the years 2016 and 2019, parents of children with FMF were asked to complete a questionnaire regarding the presence of neurological and developmental symptoms in their children with and without FMF. Demographic data, clinical characteristics, and disease course of FMF patients were collected from the medical charts. Neurodevelopmental manifestations were compared between the children with FMF and their siblings. A total of 205 children were enrolled (11.6 ± 4.7 years of age): 111 children with FMF and 94 healthy siblings in the control group. Neurological morbidity was frequently reported in children with FMF: 44 (40%) had recurrent headaches, 31 (28%) ADHD symptoms, 27 (24%) learning disabilities, and 10 (9%) febrile convulsions. Headaches and febrile convulsions were significantly more prevalent in children with FMF as compared to their siblings (ps < 0.05). ADHD and learning disabilities were associated with poor adherence to colchicine treatment.Conslusions: The present study found an increased prevalence of ADHD, learning disabilities, headaches, and febrile seizures in children with FMF. The findings underscore the importance of addressing the neurodevelopmental domain in children with FMF. In addition, detection and treatment of ADHD and learning disabilities could improve adherence with therapy and control of the underlying disease. What is Known: • Familial Mediterranean fever (FMF) is the most common inherited auto-inflammatory disease, characterized by recurrent attacks of fever, serositis, and arthritis. • Some previous case reports also described rare neurological manifestations in children with FMF. What is New: • The study found an increased prevalence of headaches, febrile seizures, ADHD, and learning disabilities, in children with FMF. • The findings underscore the importance of addressing the neurological domain in this population, which could potentially improve adherence with therapy and control of the underlying disease.

Indexed as

Familial Mediterranean FeverAdolescentChildColchicineDisease ProgressionFeverHumansPyrinSiblingsSurveys and QuestionnairesColchicinePyrinAttention-deficit hyperactivity disorderAutoinflammatoryDevelopmental delayFamilial Mediterranean feverFebrile seizuresMEFV gene; Neurological and developmental symptoms

Identifiers

PMID34652509
OpenAlexW3205960013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.